Birgit Agerholm-Larsen

2.8k total citations
26 papers, 2.0k citations indexed

About

Birgit Agerholm-Larsen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Birgit Agerholm-Larsen has authored 26 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Birgit Agerholm-Larsen's work include Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Renin-Angiotensin System Studies (6 papers) and Cholesterol and Lipid Metabolism (5 papers). Birgit Agerholm-Larsen is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Renin-Angiotensin System Studies (6 papers) and Cholesterol and Lipid Metabolism (5 papers). Birgit Agerholm-Larsen collaborates with scholars based in Denmark, United States and United Kingdom. Birgit Agerholm-Larsen's co-authors include Børge G. Nordestgaard, Anne Tybjærg‐Hansen, Wengen Chen, Alan R. Tall, Laurent O. Martinez, Rolf Steffensen, Nan Wang, Gorm Jensen, David L. Silver and Patrick Linsel‐Nitschke and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Circulation.

In The Last Decade

Birgit Agerholm-Larsen

24 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Agerholm-Larsen Denmark 19 941 803 584 581 309 26 2.0k
Sally P.A. McCormick New Zealand 25 1.0k 1.1× 437 0.5× 632 1.1× 398 0.7× 190 0.6× 59 2.1k
S Ishibashi Japan 8 662 0.7× 385 0.5× 685 1.2× 355 0.6× 109 0.4× 11 1.9k
Marianne Abifadel France 23 1.9k 2.0× 425 0.5× 572 1.0× 269 0.5× 86 0.3× 45 2.4k
Poulabi Banerjee United States 17 1.1k 1.2× 588 0.7× 400 0.7× 799 1.4× 83 0.3× 48 1.9k
Hagai Tavori United States 24 1.2k 1.3× 232 0.3× 369 0.6× 263 0.5× 69 0.2× 47 1.8k
Sadao Takahashi Japan 25 639 0.7× 424 0.5× 780 1.3× 524 0.9× 98 0.3× 60 1.9k
Glenna L. Fry United States 21 472 0.5× 390 0.5× 614 1.1× 470 0.8× 92 0.3× 34 1.9k
Cristina Zanchi Italy 24 306 0.3× 262 0.3× 612 1.0× 287 0.5× 100 0.3× 30 2.1k
Maaike Kockx Australia 25 876 0.9× 494 0.6× 1.1k 1.9× 189 0.3× 390 1.3× 60 2.3k

Countries citing papers authored by Birgit Agerholm-Larsen

Since Specialization
Citations

This map shows the geographic impact of Birgit Agerholm-Larsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Agerholm-Larsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Agerholm-Larsen more than expected).

Fields of papers citing papers by Birgit Agerholm-Larsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Agerholm-Larsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Agerholm-Larsen. The network helps show where Birgit Agerholm-Larsen may publish in the future.

Co-authorship network of co-authors of Birgit Agerholm-Larsen

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Agerholm-Larsen. A scholar is included among the top collaborators of Birgit Agerholm-Larsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Agerholm-Larsen. Birgit Agerholm-Larsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahmood, Faisal, Rasmus Hvass Hansen, Birgit Agerholm-Larsen, et al.. (2015). Detection of electroporation-induced membrane permeabilization states in the brain using diffusion-weighted MRI. Acta Oncologica. 54(3). 289–297. 12 indexed citations
2.
Agerholm-Larsen, Birgit, et al.. (2012). Effect of electrochemotherapy with IV bleomycin on complete response in a preclinical brain tumor study.. Journal of Clinical Oncology. 30(15_suppl). 2069–2069. 1 indexed citations
3.
Agerholm-Larsen, Birgit, et al.. (2011). Efficiency of Cellular Delivery of Antisense Peptide Nucleic Acid by Electroporation Depends on Charge and Electroporation Geometry. Oligonucleotides. 21(1). 29–37. 19 indexed citations
4.
Mahmood, Faisal, et al.. (2011). Diffusion-Weighted MRI for Verification of Electroporation-Based Treatments. The Journal of Membrane Biology. 240(3). 131–138. 18 indexed citations
5.
Agerholm-Larsen, Birgit, Helle K. Iversen, Per Ibsen, et al.. (2011). Preclinical Validation of Electrochemotherapy as an Effective Treatment for Brain Tumors. Cancer Research. 71(11). 3753–3762. 71 indexed citations
6.
Ravn, Lasse Steen, Marianne Benn, Børge G. Nordestgaard, et al.. (2008). Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population. Pharmacogenetics and Genomics. 18(6). 525–533. 29 indexed citations
7.
Boomsma, Frans, Ulrik Pedersen‐Bjergaard, Birgit Agerholm-Larsen, et al.. (2005). Association between plasma activities of semicarbazide-sensitive amine oxidase and angiotensin-converting enzyme in patients with type 1 diabetes mellitus. Diabetologia. 48(5). 1002–1007. 18 indexed citations
8.
Pedersen‐Bjergaard, Ulrik, Birgit Agerholm-Larsen, Stig Pramming, P. Hougaard, & Birger Thorsteinsson. (2003). Prediction of Severe Hypoglycaemia by Angiotensin-Converting Enzyme Activity and Genotype in Type 1 Diabetes. Diabetologia. 46(1). 89–96. 71 indexed citations
9.
Wang, Nan, Wengen Chen, Patrick Linsel‐Nitschke, et al.. (2003). A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. Journal of Clinical Investigation. 111(1). 99–107. 220 indexed citations
10.
Martinez, Laurent O., Birgit Agerholm-Larsen, Nan Wang, Wengen Chen, & Alan R. Tall. (2003). Phosphorylation of a Pest Sequence in ABCA1 Promotes Calpain Degradation and Is Reversed by ApoA-I. Journal of Biological Chemistry. 278(39). 37368–37374. 163 indexed citations
11.
Wang, Nan, Wengen Chen, Patrick Linsel‐Nitschke, et al.. (2003). A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. Journal of Clinical Investigation. 111(1). 99–107. 209 indexed citations
12.
Pedersen‐Bjergaard, Ulrik, Birgit Agerholm-Larsen, Stig Pramming, Philip Hougaard, & Birger Thorsteinsson. (2001). Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus. The Lancet. 357(9264). 1248–1253. 96 indexed citations
13.
Agerholm-Larsen, Birgit, Børge G. Nordestgaard, & Anne Tybjærg‐Hansen. (2000). ACE Gene Polymorphism in Cardiovascular Disease. Arteriosclerosis Thrombosis and Vascular Biology. 20(2). 484–492. 244 indexed citations
14.
Pedersen‐Bjergaard, Ulrik, Birgit Agerholm-Larsen, Stig Pramming, & Birger Thorsteinsson. (2000). High serum ACE is associated with high rate of severe hypoglycaemia in type 1 diabetic patients. Diabetes Research and Clinical Practice. 50. 310–310. 2 indexed citations
15.
Frikke‐Schmidt, Ruth, Børge G. Nordestgaard, Birgit Agerholm-Larsen, Peter Schnohr, & Anne Tybjærg‐Hansen. (2000). Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. Journal of Lipid Research. 41(11). 1812–1822. 81 indexed citations
16.
17.
Nordestgaard, Børge G., Birgit Agerholm-Larsen, & Steen Stender. (1997). Effect of exogenous hyperinsulinaemia on atherogenesis in cholesterol-fed rabbits. Diabetologia. 40(5). 512–520. 29 indexed citations
18.
Agerholm-Larsen, Birgit, Børge G. Nordestgaard, Rolf Steffensen, et al.. (1997). ACE Gene Polymorphism: Ischemic Heart Disease and Longevity in 10 150 Individuals. Circulation. 95(10). 2358–2367. 155 indexed citations
19.
Nordestgaard, Børge G., et al.. (1996). A prospective cardiovascular population study used in genetic epidemiology. The Copenhagen City Heart Study. Scandinavian Journal of Clinical and Laboratory Investigation. 56. 65–71.
20.
Nordestgaard, Børge G., Birgit Agerholm-Larsen, Hans H. Wittrup, & Anne Tybjærg‐Hansen. (1996). A prospective cardiovascular population study used in genetic epidemiology. The Copenhagen City Heart Study. Scandinavian Journal of Clinical and Laboratory Investigation. 56(sup226). 65–71. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sally P.A. McCormick Breakdown of academic impact, for papers by S Ishibashi Breakdown of academic impact, for papers by Marianne Abifadel Breakdown of academic impact, for papers by Poulabi Banerjee Breakdown of academic impact, for papers by Hagai Tavori Breakdown of academic impact, for papers by Sadao Takahashi Breakdown of academic impact, for papers by Glenna L. Fry Breakdown of academic impact, for papers by Cristina Zanchi Breakdown of academic impact, for papers by Maaike Kockx
Rankless by CCL
2026